Source: Eur Respir J 2016; 48: 1261-1264
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Louise Fleming, Sejal Saglani and Andrew Bush. Asthma attacks: should we nail our colours to the mast (cell)?. Eur Respir J 2016; 48: 1261-1264

Member's Comments

No comment yet.

Related content which might interest you: Asthma in cleaners: a distinct phenotype? Source: International Congress 2018 – Occupational and environmental lung diseases: asthma and the airways Year: 2018 Mast cell infiltration and epithelial damage in children with episodic wheezing Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Do volatile organic compounds (VOCs) discriminate between eosinophilic and neutrophilic asthma phenotype? Source: International Congress 2015 – Phenotyping asthma with biomarkers Year: 2015 Allergic versus non allergic asthma: What makes the difference? Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Heterogeneous levels of CD86+CD209+ and CD83+CD209+ dendritic cells in patients with different severity of bronchial asthma Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 Association between Type 2 innate lymphoid cells increasement and allergy in patients with chronic rhinosinusitis and asthma Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016 Mast cells in asthma: Here I am, stuck in the middle with you Source: Eur Respir J, 56 (1) 2001337; 10.1183/13993003.01337-2020 Year: 2020 Mast cell gene signature enrichment associates with late-onset severe asthma Source: International Congress 2016 – Phenotyping asthma Year: 2016 Discrimination of bronchial inflammatory phenotype of asthmatic patients by using the electronic nose Source: Annual Congress 2013 –Origins and diagnosis of asthma Year: 2013 Characterisation of lung-resident pericytes in a house dust mite-driven model of asthma Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Asthma phenotypes in children: Allergic versus non allergic Source: International Congress 2016 – Living with asthma around the globe Year: 2016 Peripheral pathological ILC2: An inflammatory indicator for the assessment of asthma control in clinics Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016 Asthma with nasal polyps: The “severe” phenotype? ClinicalTrials.gov ID: NCT01513837 Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014 Chronic rhinosinusitis with and without nasal polyps and rhinitis in adult asthma. Frequency distribution and relationship with asthma control and severity (the IRIS-ASMA study) Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013 Expression of mRNA chemokine and their receptors in nasopharingeal brush-biopsies represents age of bronchial asthma patients Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 The dynamic change of IL-25 and its receptor expression during allergen challenge in asthmatic subjects Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma Year: 2015 RV-infection modifies DNA-methylation in nasal airway epithelium cell line: Evaluation as a possible asthma trigger Source: International Congress 2014 – Paediatric asthma: pathogenesis and immunology Year: 2014 Gender differences in patients with aspirin-induced asthma (AIA) Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Outcomes with omalizumab in Indian patients with allergic (IgE-mediated) asthma: Results at 16 and 28 weeks Source: Annual Congress 2013 –Treatment of asthma Year: 2013